Literature DB >> 19171490

Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma.

Nitika Badjatia1, Abhigyan Satyam, Prabhjot Singh, Amlesh Seth, Alpana Sharma.   

Abstract

OBJECTIVES: Urothelial carcinoma of bladder is the second most common urological malignancy after prostate cancer. Recently, there has been increased interest in research of the role of free radicals and antioxidant materials in the prevention, treatment, and alleviation of therapy-related side effects of cancer. In the present study, we aimed to assess the alterations in the levels of antioxidant vitamins, activities of defense enzymes, circulating lipid peroxide, and total antioxidant activity (AOA) in patients with urothelial carcinoma of bladder and correlate these changes with the grade and severity of the disease.
MATERIALS AND METHODS: The study cohort consisted of 90 subjects; 50 patients with bladder UC (25, low grade; 10, high grade; 15, muscle invasive) and 40 healthy controls. Vitamins C and E, malondialdehyde (MDA), and AOA were estimated using standard protocols. Superoxide dismutase (SOD) and glutathione peroxidase (GPx) were assayed using commercially available kits.
RESULTS: The serum levels of vitamins C and E, whole blood levels of SOD and GPx, and serum AOA was significantly lower (P < 0.001) while serum MDA levels were significantly higher (P < 0.001) in patients than in controls, indicating presence of oxidative stress in bladder UC patients. The levels of all the biochemical parameters were correlated with the grade and severity of the disease. There were significant differences between the patients with low grade tumors and muscle invasive tumors for all parameters (P < 0.001); except AOA (P < 0.279).
CONCLUSIONS: The observed redox imbalance in UC of bladder in correlation with the grade and stage, as a consequence of decreased levels of antioxidant vitamins, enzymes, and AOA, along with increased MDA levels in circulation, may be important factors in tumor development and growth. Our results suggest that with advancing stage of bladder UC, the levels of oxidative stress increase, while levels of antioxidant molecules decrease. These findings suggest possible use of antioxidant supplementation as prophylactic agents for prevention and treatment of bladder cancer. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171490     DOI: 10.1016/j.urolonc.2008.12.010

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  25 in total

1.  Paraoxonase and arylesterase activity in bladder cancer.

Authors:  Mehmet Mazhar Utanğaç; Ercan Yeni; Murat Savaş; Adem Altunkol; Halil Çiftçi; Kemal Gümüş; Mehmet Demir
Journal:  Turk J Urol       Date:  2017-05-03

2.  Oxidant/anti-oxidant dynamics in patients with advanced cervical cancer: correlation with treatment response.

Authors:  Alpana Sharma; Medha Rajappa; Abhigyan Satyam; Manoj Sharma
Journal:  Mol Cell Biochem       Date:  2010-03-31       Impact factor: 3.396

3.  GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.

Authors:  I-Wei Chang; Victor Chia-Hsiang Lin; Chih-Hsin Hung; Hua-Pin Wang; Yung-Yao Lin; Wen-Jeng Wu; Chun-Nung Huang; Ching-Chia Li; Wei-Ming Li; Jui-Yu Wu; Chien-Feng Li
Journal:  World J Urol       Date:  2015-03-27       Impact factor: 4.226

4.  Modulating effect of d-carvone on 1,2-dimethylhydrazine-induced pre-neoplastic lesions, oxidative stress and biotransforming enzymes, in an experimental model of rat colon carcinogenesis.

Authors:  R Vinothkumar; M Sudha; P Viswanathan; J Kabalimoorthy; T Balasubramanian; N Nalini
Journal:  Cell Prolif       Date:  2013-09-30       Impact factor: 6.831

5.  Trace elements and vitamin E status in Nigerian patients with prostate cancer.

Authors:  O A Adaramoye; O Akinloye; I K Olatunji
Journal:  Afr Health Sci       Date:  2010-03       Impact factor: 0.927

6.  Antioxidant supplementation has a positive effect on oxidative stress and hematological toxicity during oncology treatment in cervical cancer patients.

Authors:  Vanessa Fuchs-Tarlovsky; María Amanda Casillas Rivera; Karolina Alvarez Altamirano; Juan Carlos Lopez-Alvarenga; Guillermo Manuel Ceballos-Reyes
Journal:  Support Care Cancer       Date:  2012-12-14       Impact factor: 3.603

7.  Genetic variants of MnSOD and GPX1 and susceptibility to bladder cancer in a Turkish population.

Authors:  Canan Kucukgergin; Oner Sanli; Akın S Amasyalı; Tzevat Tefik; Sule Seckin
Journal:  Med Oncol       Date:  2011-09-09       Impact factor: 3.064

8.  Interrelationship between angiogenesis, inflammation and oxidative stress in Indian patients with multiple myeloma.

Authors:  S Joshi; N Gupta; R Khan; R Kumar; M Sharma; L Kumar; A Sharma
Journal:  Clin Transl Oncol       Date:  2015-07-14       Impact factor: 3.405

9.  In vivo detection of a novel endogenous etheno-DNA adduct derived from arachidonic acid and the effects of antioxidants on its formation.

Authors:  Ying Fu; Raghu G Nath; Marcin Dyba; Idalia M Cruz; Sharanya R Pondicherry; Aileen Fernandez; Casey L Schultz; Peiying Yang; Jishen Pan; Dhimant Desai; Jacek Krzeminski; Shantu Amin; Plamen P Christov; Yukihiko Hara; Fung-Lung Chung
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

10.  GSTM1-null and GSTA1-low activity genotypes are associated with enhanced oxidative damage in bladder cancer.

Authors:  Ana Savic-Radojevic; Tatjana Djukic; Tatjana Simic; Marija Pljesa-Ercegovac; Dejan Dragicevic; Tatjana Pekmezovic; Milica Cekerevac; Veljko Santric; Marija Matic
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.